The Evaluation of Quality of Life by the Short-Form 36 Health Survey (SF-36) in Patients with Obstuructive Sleep Apnea Hypopnea Syndrome (OSAHS), Who Use Continuous Positive Airway Pressure (CPAP) for Long Term.

Author(s):  
S Nojiri ◽  
Y Yumino ◽  
S Minagawa ◽  
J Kojima ◽  
T Numata ◽  
...  
2016 ◽  
Vol 25 (6) ◽  
pp. 731-738 ◽  
Author(s):  
Salma Batool-Anwar ◽  
James L. Goodwin ◽  
Clete A. Kushida ◽  
James A. Walsh ◽  
Richard D. Simon ◽  
...  

2014 ◽  
Vol 44 (5) ◽  
pp. 1262-1274 ◽  
Author(s):  
Izolde Bouloukaki ◽  
Katerina Giannadaki ◽  
Charalampos Mermigkis ◽  
Nikolaos Tzanakis ◽  
Eleni Mauroudi ◽  
...  

We aimed to compare the effect of intensiveversusstandard interventions on continuous positive airway pressure (CPAP) adherence 2 years after CPAP initiation, as well as on sleepiness, quality of life, depression, hospitalisation and death rate due to cardiovascular disease (CVD).3100 patients with newly diagnosed sleep apnoea were randomised into the standard group, with usual follow-up care, or the intensive group, with additional visits, telephone calls and education. Subjective daytime sleepiness (Epworth Sleepiness Scale; ESS), quality of life (36-item Short Form Health Survey; SF-36) and the patient’s level of depression (Beck Depression Inventory; BDI) were recorded before and 2 years after CPAP initiation, together with CVD hospitalisations and death rate.2 years after CPAP initiation, the intensive group used CPAP significantly more than the standard group (6.9versus5.2 h per night; p<0.001). ESS, SF-36 and BDI scores were also significantly better in the intensive group. Furthermore, the standard group had significantly more deaths and hospitalisations due to CVD.CPAP usage can be improved by both intensive and standard patient support. However, the patients who received intensive CPAP support had significantly better ESS, BDI and SF-36 scores, and lower cardiovascular morbidity and mortality, suggesting that an intensive programme could be worthwhile.


CHEST Journal ◽  
2007 ◽  
Vol 132 (4) ◽  
pp. 646A
Author(s):  
Irene Avlonitou ◽  
Fotis Kapsimalis ◽  
George Varouchakis ◽  
Miltos Vassiliou ◽  
Panagiotis Behrakis

2020 ◽  
Vol 27 (2) ◽  
pp. 73-82
Author(s):  
Ji Ho Choi

Obstructive sleep apnea (OSA) is characterized by repeated events of complete or partial upper airway obstruction during sleep and is a chronic sleep disorder that requires long-term comprehensive management. Positive airway pressure (PAP) is recommended for treatment of OSA in adults with excessive daytime sleepiness, decreased sleep-related quality of life, and comorbid hypertension. During PAP therapy, regular follow-up is continuously necessary to evaluate side effects or complications, compliance, and treatment effects such as OSA-related symptoms, quality of life, and consequences. This review provides knowledge about PAP-related background information, indications for PAP prescription including the Korean National Health Insurance criteria, optimal pressure, PAP modes, patient education and support, short-term and long-term management, interpretation of PAP uses, and alternative therapies.


Sign in / Sign up

Export Citation Format

Share Document